EUTM file information

018230824

NYMOFEX


April 26, 2020

Trademark Summary

The trademark application NYMOFEX was filed by Nymox Pharmaceutical Corporation, Ltd, a corporation established under the laws of the Commonwealth of the Bahamas (the "Applicant"). The application was published for oppositions on May 24, 2020, and it was registered by office on August 31, 2020 without any oppositions.

The application was filed in English (French was selected as the second language).

Change of name and address of the trademark registration was recorded on December 1, 2020.


Goods And Services

  • The mark was filed in class 5 with Pharmaceutical preparations for the treatment of benign prostatic hyperplasia and prostate cancer.
Trademarkers